281 results
Molecular Operating Environment: Antibody Modelling and Protein Engineering Software
Proteins, Antibodies & ADCs

Molecular Operating Environment: Antibody Modelling and Protein Engineering Software

Technology Spotlight
May , 2025
Gene-Edited Tumour-Infiltrating Lymphocytes Show Clinical Promise Against Advanced Colorectal Cancers
Cell & Gene

Gene-Edited Tumour-Infiltrating Lymphocytes Show Clinical Promise Against Advanced Colorectal Cancers

News
May , 2025
Novel Approaches to Fc Receptor Function in Antibody Design
Proteins, Antibodies & ADCs

Novel Approaches to Fc Receptor Function in Antibody Design

Technology Spotlight
May , 2025
Redefining Insulin with Recombinant Expression
Proteins, Antibodies & ADCs Peptides

Redefining Insulin with Recombinant Expression

Market Insight
May , 2025
IMAAVY Receives Seal of Approval from the FDA as First-in-Class Treatment for Generalised Myasthenia Gravis (gMG)
Proteins, Antibodies & ADCs

IMAAVY Receives Seal of Approval from the FDA as First-in-Class Treatment for Generalised Myasthenia Gravis (gMG)

News
May , 2025
Reeves, Trump, and the ‘Tariff Wall’: Can a Trade Deal Provide for UK Pharma?
Proteins, Antibodies & ADCs

Reeves, Trump, and the ‘Tariff Wall’: Can a Trade Deal Provide for UK Pharma?

News
May , 2025
Time is of the Essence: Why 2025 is a Unique Opportunity for APAC Biotech
Proteins, Antibodies & ADCs

Time is of the Essence: Why 2025 is a Unique Opportunity for APAC Biotech

News
May , 2025
COATSOME® SS Series: Low-Toxicity LNPs with Biodegradable Ionizable Lipids
Vaccines

COATSOME® SS Series: Low-Toxicity LNPs with Biodegradable Ionizable Lipids

Technology Spotlight
May , 2025
Macrophage-Targeted Therapeutics: Discovery, Modelling, and AI-Driven Analysis
Proteins, Antibodies & ADCs

Macrophage-Targeted Therapeutics: Discovery, Modelling, and AI-Driven Analysis

Technology Spotlight
May , 2025
Evaluating Immuno-Oncology Drug Candidates with Novel Bioassays
Proteins, Antibodies & ADCs

Evaluating Immuno-Oncology Drug Candidates with Novel Bioassays

Technology Spotlight
May , 2025
Harnessing Antigen-Specific T Cells and Tonsil Organoids for Advanced Therapeutic Insights
Proteins, Antibodies & ADCs

Harnessing Antigen-Specific T Cells and Tonsil Organoids for Advanced Therapeutic Insights

Technology Spotlight
May , 2025
Pushing the Boundaries of Precision Proteomics with Olink
Proteins, Antibodies & ADCs

Pushing the Boundaries of Precision Proteomics with Olink

Technology Spotlight
May , 2025
Antigen Density Matters: Advancing Immune-Targeted Cancer Therapies
Proteins, Antibodies & ADCs

Antigen Density Matters: Advancing Immune-Targeted Cancer Therapies

Technology Spotlight
May , 2025
How You Can Use Humanised Mice to Develop Immunotherapies
Proteins, Antibodies & ADCs

How You Can Use Humanised Mice to Develop Immunotherapies

Technology Spotlight
May , 2025
How Advances in Multiomics are Pushing Us Toward the Generation Cancer Therapeutics
Proteins, Antibodies & ADCs

How Advances in Multiomics are Pushing Us Toward the Generation Cancer Therapeutics

Technology Spotlight
May , 2025
Inhalable mRNA-LNP Quality Control and Formulation Case Study
Oligonucleotides

Inhalable mRNA-LNP Quality Control and Formulation Case Study

Technology Spotlight
May , 2025
Your Centre of Excellence in Tides Development and Manufacturing Since 1976
Peptides

Your Centre of Excellence in Tides Development and Manufacturing Since 1976

Technology Spotlight
May , 2025
Sustainable, Efficient, and Pure: Combining the Benefits of Solid and Liquid Phase Peptide Synthesis
Peptides

Sustainable, Efficient, and Pure: Combining the Benefits of Solid and Liquid Phase Peptide Synthesis

Technology Spotlight
May , 2025
From Molecule to Market: Your Trusted Partner
Peptides

From Molecule to Market: Your Trusted Partner

Technology Spotlight
May , 2025
Three Innovations for Green and Controlled Peptide Manufacture
Peptides

Three Innovations for Green and Controlled Peptide Manufacture

Technology Spotlight
May , 2025
Path To IND For Biologics: Ready For Phase I In 12 Months
Proteins, Antibodies & ADCs

Path To IND For Biologics: Ready For Phase I In 12 Months

Technology Spotlight
May , 2025